With 0.56 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.24 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $27.49 whereas the lowest price it dropped to was $25.75. The 52-week range on SION shows that it touched its highest point at $27.39 and its lowest point at $7.26 during that stretch. It currently has a 1-year price target of $38.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SION was up-trending over the past week, with a rise of 21.87%, but this was up by 12.55% over a month. Three-month performance surged to 80.90% while six-month performance rose 109.44%. For the next quarter, that number is -0.48. This implies an EPS growth rate of 87.41% for this year and -10.29% for next year.
Float and Shares Shorts:
At present, 44.13 million SION shares are outstanding with a float of 23.40 million shares on hand for trading. On 2025-08-29, short shares totaled 3.48 million, which was 787.0000000000001 higher than short shares on 1753920000. In addition to Mr. Michael Cloonan M.B.A. as the firm’s President, CEO & Director, Ms. Elena H. Ridloff C.F.A. serves as its CFO & Head of Corporate Development.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, SION reported revenue of $0.0 and operating income of -$21906000.0. The EBITDA in the recently reported quarter was -$21428000.0 and diluted EPS was -$0.41.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With SION analysts setting a high price target of 46.0 and a low target of 22.0, the average target price over the next 12 months is 38.0. Based on these targets, SION could surge 69.87% to reach the target high and fall by -18.76% to reach the target low. Reaching the average price target will result in a growth of 40.32% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$5.26333 being high and -$5.26333 being low. For SION, this leads to a yearly average estimate of -$5.26333.
